Valuation: Illumina, Inc.

Capitalization 23.52B 20.02B 18.59B 17.43B 32.46B 2,155B 34.42B 212B 84.12B 1,018B 88.21B 86.4B 3,724B P/E ratio 2025 *
33.9x
P/E ratio 2026 * 34.7x
Enterprise value 24.71B 21.03B 19.53B 18.31B 34.1B 2,263B 36.15B 223B 88.35B 1,069B 92.65B 90.75B 3,912B EV / Sales 2025 *
5.76x
EV / Sales 2026 * 5.45x
Free-Float
79.72%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.96%
1 week+5.95%
Current month+17.38%
1 month+11.88%
3 months+58.34%
6 months+50.89%
Current year+17.38%
More quotes
1 week 137
Extreme 137
155.53
1 month 130.42
Extreme 130.42
155.53
Current year 130.42
Extreme 130.42
155.53
1 year 68.7
Extreme 68.7
155.53
3 years 68.7
Extreme 68.7
238.55
5 years 68.7
Extreme 68.7
555.77
10 years 68.7
Extreme 68.7
555.77
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer - 09/08/2023
Director TitleAgeSince
Director/Board Member 71 29/11/2012
Director/Board Member 69 28/01/2016
Director/Board Member 65 28/07/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.96%+5.95%+9.68%-24.68% 23.52B
+0.50%+2.37%+11.29%+7.71% 240B
+0.40%-2.87%-13.87%+104.78% 186B
-0.81%+0.08%-1.68%-12.51% 170B
-0.46%+1.40%-8.99%+100.11% 135B
-1.17%-5.68%-19.64%-10.88% 57.83B
-0.82%-0.06%+22.31%+6.50% 49B
-0.82%-4.28%-9.15%-11.09% 39.3B
-1.52%-2.05%+3.24%+8.78% 37.19B
+0.97%-0.75%-6.23%+22.64% 37.3B
Average -0.28%-0.60%-1.30%+19.14% 97.58B
Weighted average by Cap. -0.15%-0.24%-1.70%+33.47%
See all sector performances

Financials

2025 *2026 *
Net sales 4.29B 3.65B 3.39B 3.18B 5.92B 393B 6.28B 38.72B 15.34B 186B 16.09B 15.76B 679B 4.41B 3.75B 3.49B 3.27B 6.09B 404B 6.45B 39.81B 15.77B 191B 16.54B 16.2B 698B
Net income 658M 560M 520M 488M 908M 60.27B 963M 5.94B 2.35B 28.47B 2.47B 2.42B 104B 678M 577M 536M 503M 936M 62.12B 992M 6.12B 2.43B 29.35B 2.54B 2.49B 107B
Net Debt 1.18B 1.01B 935M 877M 1.63B 108B 1.73B 10.68B 4.23B 51.2B 4.44B 4.35B 187B 520M 443M 411M 386M 718M 47.66B 761M 4.7B 1.86B 22.51B 1.95B 1.91B 82.39B
More financial data * Estimated data
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
9,000
More about the company
Date Price Change Volume
22/01/26 153.95 $ +0.96% 1,668,196
21/01/26 152.48 $ +3.61% 2,269,034
20/01/26 147.17 $ +3.90% 2,090,295
16/01/26 141.65 $ -2.51% 1,901,812
15/01/26 145.30 $ +0.92% 1,700,422

Delayed Quote Nasdaq, January 23, 2026 at 01:00 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
153.95USD
Average target price
133.24USD
Spread / Average Target
-13.46%
Consensus

Quarterly revenue - Rate of surprise